As of 2024-07-27, the Relative Valuation of MEI Pharma Inc (MEIP) is 121.52 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.56 USD, the upside of MEI Pharma Inc based on Relative Valuation is 3313.6%.
The range of the Relative Valuation is 108.29 - 149.83 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 38.2x | 31.8x |
| Forward P/E multiples | 27.6x - 30.5x | 30.1x |
| Fair Price | 108.29 - 149.83 | 121.52 |
| Upside | 2941.9% - 4108.8% | 3313.6% |
| Date | P/E |
| 2024-07-26 | 0.91 |
| 2024-07-25 | 0.88 |
| 2024-07-24 | 0.84 |
| 2024-07-23 | 0.93 |
| 2024-07-22 | 0.88 |
| 2024-07-19 | 0.73 |
| 2024-07-18 | 0.73 |
| 2024-07-17 | 0.74 |
| 2024-07-16 | 0.73 |
| 2024-07-15 | 0.72 |
| 2024-07-12 | 0.74 |
| 2024-07-11 | 0.72 |
| 2024-07-10 | 0.71 |
| 2024-07-09 | 0.71 |
| 2024-07-08 | 0.72 |
| 2024-07-05 | 0.71 |
| 2024-07-03 | 0.72 |
| 2024-07-02 | 0.71 |
| 2024-07-01 | 0.73 |
| 2024-06-28 | 0.74 |
| 2024-06-27 | 0.75 |
| 2024-06-26 | 0.73 |
| 2024-06-25 | 0.73 |
| 2024-06-24 | 0.71 |
| 2024-06-21 | 0.73 |
| 2024-06-20 | 0.72 |
| 2024-06-18 | 0.72 |
| 2024-06-17 | 0.73 |
| 2024-06-14 | 0.74 |
| 2024-06-13 | 0.75 |
| 2024-06-12 | 0.73 |
| 2024-06-11 | 0.72 |
| 2024-06-10 | 0.73 |
| 2024-06-07 | 0.73 |
| 2024-06-06 | 0.73 |
| 2024-06-05 | 0.73 |
| 2024-06-04 | 0.71 |
| 2024-06-03 | 0.74 |
| 2024-05-31 | 0.73 |
| 2024-05-30 | 0.74 |
| 2024-05-29 | 0.74 |
| 2024-05-28 | 0.78 |
| 2024-05-24 | 0.79 |
| 2024-05-23 | 0.80 |
| 2024-05-22 | 0.81 |
| 2024-05-21 | 0.79 |
| 2024-05-20 | 0.79 |
| 2024-05-17 | 0.80 |
| 2024-05-16 | 0.75 |
| 2024-05-15 | 0.79 |